Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

Zhi Chen1, Arian Laurence1, Yuka Kanno1, Margit Pacher‐Zavisin2, Bing Zhu2, Cristina M. Tato1, Akihiko Yoshimura3, Lothar Hennighausen2, John J. O’Shea1
1*Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and
2Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; and
3Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan

Tóm tắt

Suppressor of cytokine signaling (Socs) 3 is a cytokine-inducible inhibitor with critical but selective cell-specific effects. We show that deficiency of Socs3 in T cells had minimal effects on differentiation of T cells to the T helper (Th) 1 or Th2 subsets; accordingly, Socs3 had no effect on IL-12-dependent signal transducer and activator of transcription (Stat) 4 phosphorylation or IL-4-dependent Stat6 phosphorylation. By contrast, Socs3 was found to be a major regulator of IL-23-mediated Stat3 phosphorylation and Th17 generation, and Stat3 directly binds to theIL-17AandIL-17Fpromoters. We conclude that Socs3 is an essential negative regulator of IL-23 signaling, inhibition of which constrains the generation of Th17 differentiation.

Từ khóa


Tài liệu tham khảo

10.1182/blood.V97.4.1056

10.1016/S0303-7207(99)00175-6

10.1146/annurev.immunol.22.091003.090312

10.1016/S0092-8674(02)00701-8

10.1002/j.1460-2075.1995.tb07281.x

10.1038/43213

10.1093/emboj/18.2.375

10.1073/pnas.96.5.2071

10.1101/gad.12.24.3872

10.1634/stemcells.19-5-378

10.1038/nri818

10.1016/S0092-8674(00)80047-1

10.1038/35016611

10.1074/jbc.C200450200

10.1093/emboj/cdg057

10.1073/pnas.0508023102

10.1038/nm1071

10.1016/S1074-7613(04)00022-6

10.1074/jbc.C300496200

10.1038/ni931

10.1016/j.bbrc.2005.10.171

10.1038/ni932

10.1038/ni938

10.1016/S0092-8674(00)80049-5

10.1038/nri954

10.1007/978-1-4615-5855-2_9

10.1084/jem.181.5.1755

10.1073/pnas.92.16.7307

10.1038/380630a0

10.1038/380627a0

10.1038/nm896

10.4049/jimmunol.174.7.4105

10.1038/ni1254

10.1038/ni1261

10.1038/ni1255

10.1084/jem.20050193

10.1016/j.immuni.2004.08.018

10.1016/S1359-6101(03)00002-9

10.1074/jbc.M207577200

10.4049/jimmunol.168.11.5699

10.1002/jcb.240590407

10.1023/A:1013063514007

10.1073/pnas.0400339101

10.1634/stemcells.2005-0323

10.1016/j.bbrc.2005.10.138

10.1016/j.immuni.2006.01.001

T. R. Mosmann, H. Cherwinski, M. W. Bond, M. A. Giedlin, R. L. Coffman J. Immunol 136, 2348–2357 (1986).

10.4049/jimmunol.168.12.6404

Y. Katz, O. Nadiv Isr. Med. Assoc. J 2, 21–22 (2000).

10.1183/09031936.02.00280902

10.1006/cyto.2000.0681

10.1136/gut.52.1.65

10.1084/jem.183.6.2593

10.1016/j.healun.2004.05.003

M. Laan, Z. H. Cui, H. Hoshino, J. Lotvall, M. Sjostrand, D. C. Gruenert, B. E. Skoogh, A. Linden J. Immunol 162, 2347–2352 (1999).

P. Schwarzenberger, V. La Russa, A. Miller, P. Ye, W. Huang, A. Zieske, S. Nelson, G. J. Bagby, D. Stoltz, R. L. Mynatt, et al. J. Immunol 161, 6383–6389 (1998).

10.4049/jimmunol.164.9.4783

10.4049/jimmunol.166.12.7563

10.1093/nar/25.21.4323

10.1074/jbc.M407576200